IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Corvus Pharmaceuticals Inc

CUSIP: 022101510 | 1 institutional holders

Quarters

Q3 2025Q4 2024
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2025

DCF Advisers, LLC768,500
1.8% of portfolio›$5.7M
StyleTurnoverLocationFiled
DCF Advisers, LLC
768,500$5.7M1.8%GARPMediumMount Pleasant, SC2025-11-12